The Global Pharmaceutical Grade Guanidine Carbonate Market reached USD 158.10 million in 2023 and is projected to expand at a CAGR of 3.50% to USD 215.47 million by 2032. This growth trajectory underscores the compound’s critical role in pharmaceutical synthesis, where high-purity standards are non-negotiable. With API synthesis dominating 65% of market applications and European...
0 Commentarios
0 Acciones
763 Views
0 Vista previa